Search results
Results from the WOW.Com Content Network
For example, if a woman at high risk has a close relative who was diagnosed with breast cancer, “a general rule is to start screening high-risk women 10 years prior to the age of that diagnosis ...
The system is designed to standardize reporting and is used by medical professionals to communicate a patient's risk of developing breast cancer, particularly for patients with dense breast tissue. The document focuses on patient reports used by medical professionals, not "lay reports" that are provided to patients.
It combines in a single non-invasive tool the capability to implement breast cancer risk assessment, [2] lesion characterization, [3] therapy monitoring [4] and prediction of therapy outcome. [5] It is an application of diffuse optics , which studies light propagation in strongly diffusive media, such as biological tissues, working in the red ...
The site began in 1998 as a pen and paper questionnaire called the Harvard Cancer Risk Index. [2] In January 2000, The Harvard Cancer Risk Index developed into an online assessment and was renamed Your Cancer Risk, and offered assessments for four cancers: breast, colon, lung, and prostate. Six months later, eight additional cancers were added. [3]
The Breast Cancer Risk Assessment Tool (BCRAT), also known as the Gail Model, is one of the most common and popular tests used to identify those women at risk for breast cancer, says Sherry Ross ...
Women who have mutations in their BRCA1 and/or BRCA2 genes are at increased risk of breast or ovarian cancer, according to the Centers for Disease Control and Prevention. Wanting to be proactive ...
Have a lifetime risk of breast cancer >20% according to risk assessment tools; History of radiation therapy to chest between 10 and 30 years of age; Have or has a 1st-degree relative with a genetic syndrome including Li-Fraumeni syndrome, Cowden syndrome, or Bannayan-Riley-Ruvalcaba syndrome [37]
The Breast Cancer Risk Assessment Tool (BCRAT) is an online calculator designed to predict a woman’s risk of developing invasive breast cancer in both the short term, within five years, and ...